The Latest Breaking News from AstraZeneca

AstraZeneca plc (NASDAQ: AZN) has granted 

The message that Pfizer was not suitable for people with allergies, especially those with a history of anaphylaxis, spread far and wide - but it is simply not true

Egypt has received four million doses of AstraZeneca’s COVID-19 vaccine from the United Kingdom, as part of the global COVAX agreement, Egypt's Health Ministry revealed. The vaccines were sent to Cairo International Airport in three batches on Thursday and Friday. Acting Health Minister Khaled Abdel-Ghaffar thanked the UK for supporting…

ICMR conducted a study on 39 individuals, of which 25 had taken both the doses of AstraZeneca COVID-19 vaccine, eight people had taken double dose of Pfizer jab, while six were unvaccinated.

The BBC radio presenter passed away due to a complication from the Covid AstraZeneca vaccine

The government is ramping up the rollout of fourth Covid-19 shots to residents in tourism-dependent regions as the nation gears up for border reopening next month.

A combination of tremelimumab and AstraZeneca Plc's (NASDAQ: AZN) Imfinzi (durvalumab) 

If history is any guide, there may be trouble ahead for shares of AstraZeneca (NASDAQ:AZN). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

For many Australians, it’s now time for a COVID booster – but which one should you be getting? Read our handy guide to find out.

Nexer Digital's headcount also increased from 55 in 2020 to 90 at the end of 2021